Would Proposed New Rule for Repricing Long-Listed Drugs Create Winners and Losers? Bill Payers Opposed, Industry Watching Closely

The Ministry of Health, Labor and Welfare (MHLW) recently proposed eliminating the current special price reduction rule for long-listed drugs and replacing it with a new rule that would reduce the NHI prices of long-listed drugs if their generics fail...read more